Sarah AlFarabi Ali

Sarah AlFarabi Ali

Auto-generated profile, based on publicly available information

Sarah AlFarabi Ali

Department of Oral Diagnostic Sciences, Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2021 in Polymers
Verified
Journal Article
Open access
PDF file
KHKhaled Hosny
Khaled Hosny
HAHala M AlKhalidi
Hala M AlKhalidi
WAWaleed Alharbi
Waleed Alharbi
Shadab MDShadab MD
Shadab MD
ASAmal Mohammed Sindi
Amal Mohammed Sindi
MKMallesh Kurakula
Mallesh Kurakula
Natural polymers are revolutionizing current pharmaceutical dosage forms design as excipient and gained huge importance because of significant influence in formulation development and drug delivery. Oral health refers to the health of the teeth, gums, and the entire oral-facial system that allows us to smile, speak, and chew. Since years, biopolymers stand out due to their biocompatibility, biodegradability, low toxicity, and stability. Polysaccharides such as cellulose and their derivatives possess properties like novel mechanical robustness and hydrophilicity that can be easily fabricated into controlled-release dosage forms. Cellulose attracts the dosage design attention because of constant drug release rate from the precursor nanoparticles. This review discusses the origin, extraction, preparation of cellulose derivatives and their use in formulation development of nanoparticles having multidisciplinary applications as pharmaceutical excipient and in drug delivery, as bacterial and plant cellulose have great potential for application in the biomedical area, including dentistry, protein and peptide delivery, colorectal cancer treatment, and in 3D printable dosage forms.

1 August 2021 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
KHKhaled Hosny
Khaled Hosny
HAHani Z Asfour
Hani Z Asfour
WRWaleed Y. Rizg
Waleed Y. Rizg
NANabil A Alhakamy
Nabil A Alhakamy
ASAmal Mohammed Sindi
Amal Mohammed Sindi
RKRasha A Khallaf
Rasha A Khallaf
Introduction: Natural oil-based nanoemulsions (NEs) have been widely investigated in many diseases that affect the oral cavity. NEs are delivery systems that enhance the solubility of lipid therapeutics and improve their delivery to target sites; they are known as self-nanoemulsifying drug delivery systems (SNEDDSs). The current investigation’s aim was to produce an oregano essential oil-based nanoemulsion (OEO-SNEDD) that would have antibacterial and antifungal effects against oral microbiota and improve oral health. Methods: Several OEO-SNEDDSs were developed using different percentages of OEO (10%, 14%, and 18%), percentages of a surfactant mixture Pluracare L64:Lauroglycol FCC (18%, 32%, and 36%), Smix ratios (1:2, 1:1, and 2:1), and hydrophilic-lipophilic balances (HLBs) of the surfactant mixture (8, 10, and 12) using the Box‒Behnken design. The optimized concentration of excipients was determined using a pseudoternary phase diagram to obtain the NEs. The formulations were evaluated for their droplet size, stability index, and antibacterial and antifungal activities. Results: The NEs had a droplet size of 150 to 500 nm and stability index of 47% to 95%, and the produced formulation reached antibacterial and antifungal inhibition zones of up to 19 and 17 mm, respectively. The Box‒Behnken design was adopted to get the optimum formulation, which was 18% OEO, 36% Smix, 10.29 HLB of Smix, and a 1.25:1 Smix ratio. The optimized formulation had a lower ulcer index compared with various other formulations evaluated in rats. Conclusion: This study illustrated that OEO-SNEDDSs can provide good protection against oral microbial infections.

9 February 2022 in Gels
Verified
Journal Article
Open access
PDF file
WRWaleed Y. Rizg
Waleed Y. Rizg
NNNimbagal Raghavendra Naveen
Nimbagal Raghavendra Naveen
MKMallesh Kurakula
Mallesh Kurakula
HBHaitham A Bukhary
Haitham A Bukhary
ASAwaji Safhi
Awaji Safhi
KHKhaled Hosny
Khaled Hosny
The goal of the current study is to develop a chitosan alginate nanoparticle system encapsulating the model drug, simvastatin (SIM-CA-NP) using a novel polyelectrolytic complexation method. The formulation was optimized using the central composite design by considering the concentrations of chitosan and alginate at five different levels (coded as +1.414, +1, 0, −1, and −1.414) in achieving minimum particle size (PS-Y1) and maximum entrapment efficiency (EE-Y2). A total of 13 runs were formulated (as projected by the Design-Expert software) and evaluated accordingly for the selected responses. On basis of the desirability approach (D = 0.880), a formulation containing 0.258 g of chitosan and 0.353 g of alginate could fulfill the prerequisites of optimum formulation in achieving 142.56 nm of PS and 75.18% EE. Optimized formulation (O-SIM-CAN) was further evaluated for PS and EE to compare with the theoretical results, and relative error was found to be within the acceptable limits, thus confirming the accuracy of the selected design. SIM release from O-SIM-CAN was retarded significantly even beyond 96 h, due to the encapsulation in chitosan alginate carriers. The cell viability study and Caspase-3 enzyme assay showed a notable difference in contrast to that of plain SIM and control group. All these stated results confirm that the alginate-chitosan nanoparticulate system enhanced the anti-proliferative activity of SIM.

1 October 2020 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
NBNada Binmadi
Nada Binmadi
MBMaram Bawazir
Maram Bawazir
NANada Alhindi
Nada Alhindi
HMHani Mawardi
Hani Mawardi
GMGhada Mansour
Ghada Mansour
SASoulafa A. Almazrooa
Soulafa A. Almazrooa
Background: Medication-induced oral hyperpigmentation is an oral condition that impacts patients’ quality of life and has been linked to many systemic therapeutic agents. The exact pathogenesis of tissue pigmentation varies greatly and is not completely known. This systematic review aimed to present data on the causal association between medications and the development of oral/mucosal pigmentation as an adverse drug reaction. Methods: A systematic review and analysis of literature were conducted using the following databases: PubMed, Science Direct, ProQuest, Web of Science, and Scopus. The systematic review included original articles written in English and published between January 1982 and June 2020. Following the PRISMA statement, eligible articles were systematically reviewed, and data were extracted from eligible studies and analyzed. Results: A total of 235 articles were identified, of which 57 met the inclusion criteria and were included in this review. The mean age of included patients was 46.2± 16.38 years (range: 10– 90 years) with a male to female ratio of 1:1.45. Oral mucosal hyperpigmentation was reported following the use of several classes of medications such as antiviral (eg, zidovudine), antibiotic (eg, minocycline), antimalarial (eg, chloroquine), anti-fungal (eg, ketoconazole), antileprotic (eg, clofazimine), antihypertensive (eg, amlodipine), chemotherapeutic, and antineoplastic drugs. The risk of developing oral pigmentation was significantly higher with antimalarial medications, antibiotics, antineoplastic and chemotherapeutic agents. Medication-induced oral hyperpigmentation was most frequent among women and in the hard palate. Conclusion: Future research is warranted to better understand the pathogenesis and risk factors for medication-induced oral hyperpigmentation in order to reassure patients during prescription and management.

7 May 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AAAlshaimaa Almehmady
Alshaimaa Almehmady
SASarah A. Ali
Sarah A. Ali
The exponentially mounting cases of herpes simplex virus infection or cold sores have become a serious global concern. Acyclovir (ACV) and garlic oil (GO)-loaded lipid nanocarrier could be a promising therapeutic approach in alleviating cold sores, as well as limiting the biopharmaceutical constraints associated with ACV absorption and therapeutic efficacy. Therefore, the objective of the current research study was to formulate an ACV-GO self-nanoemulsifying drug delivery system (ACV-GO-SNEDDS) as transdermal films. The prepared SNEDDS was optimized using an experimental mixture design. The optimized ACV-GO SNEDDS was loaded in transdermal film and was evaluated for ex vivo skin permeation and in vivo pharmacokinetic prospects. An optimized ACV-GO SNEDDs formulation constituted of 10.4% (w/w) of GO, 64.8% (w/w) of surfactant mixture (Tween 20®-Span 20®); 24.8%(w/w) of co-surfactant (Propylene glycol®), and 200mg of ACV, respectively, were prepared and characterized for particle size (Y). The observed globule size of the optimized ACV-GO SNEDDS is 170 ± 13.45 nm. The results of stability studies indicated that the stability index of optimized ACV-GO-SNEDDS was more than 92 ± 3%. This optimized ACV-GO SNEDDS was loaded in hydroxypropyl cellulose transdermal film. The outcome of the ex vivo skin permeation study demonstrated a 2.3-fold augmented permeation of ACV from the optimized ACV-GO SNEDDS HPC transdermal film in comparison to the raw ACV transdermal film. There was a 3-fold increase in the relative bioavailability of the optimized ACV-GO SNEDDS transdermal film compared to the raw ACV-HPC film. The study findings confirmed that the ACV-GO SNEDDS transdermal film exhibited excellent potential to enhance the bioavailability of ACV.

24 April 2025 in JMIR AI
Verified
Journal Article
Open access
SASarah AlFarabi Ali
Sarah AlFarabi Ali
HAHebah AlDehlawi
Hebah AlDehlawi
AHOUD JAZZARAHOUD JAZZAR
AHOUD JAZZAR
HAHeba Ashi
Heba Ashi
NANihal Abuzinadah
Nihal Abuzinadah
SASoulafa A. Almazrooa
Soulafa A. Almazrooa
Background: The use of artificial intelligence (AI), especially large language models (LLMs), is increasing in health care, including in dentistry. There has yet to be an assessment of the diagnostic performance of LLMs in oral medicine. Objective: We aimed to compare the effectiveness of ChatGPT (OpenAI) and Microsoft Copilot (integrated within the Microsoft 365 suite) with oral medicine consultants in formulating accurate differential and final diagnoses for oral lesions from written clinical scenarios. Methods: Fifty comprehensive clinical case scenarios including patient age, presenting complaint, history of the presenting complaint, medical history, allergies, intra- and extraoral findings, lesion description, and any additional information including laboratory investigations and specific clinical features were given to three oral medicine consultants, who were asked to formulate a differential diagnosis and a final diagnosis. Specific prompts for the same 50 cases were designed and input into ChatGPT and Copilot to formulate both differential and final diagnoses. The diagnostic accuracy was compared between the LLMs and oral medicine consultants. Results: ChatGPT exhibited the highest accuracy, providing the correct differential diagnoses in 37 of 50 cases (74%). There were no significant differences in the accuracy of providing the correct differential diagnoses between AI models and oral medicine consultants. ChatGPT was as accurate as consultants in making the final diagnoses, but Copilot was significantly less accurate than ChatGPT (P=.015) and one of the oral medicine consultants (P<.001) in providing the correct final diagnosis. Conclusions: ChatGPT and Copilot show promising performance for diagnosing oral medicine pathology in clinical case scenarios to assist dental practitioners. ChatGPT-4 and Copilot are still evolving, but even now, they might provide a significant advantage in the clinical setting as tools to help dental practitioners in their daily practice.